What is the Pathogenic CAG Expansion Length in Huntington's Disease?

Jasmine Donaldson1, Sophie Powell1, Nadia Rickards1

  • 1MRC Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, UK.

Insights

Huntington's disease (HD) involves CAG repeat expansion in the HTT gene. This study explores the intracellular pathogenic threshold for cell dysfunction, crucial for understanding HD mechanisms and developing treatments.

Area of Science:

  • Genetics
  • Neurodegenerative Diseases
  • Molecular Biology

Background:

  • Huntington's disease (HD) is caused by an expanded CAG repeat in the HTT gene.
  • CAG repeat length influences age of onset and disease progression.
  • Somatic and germline expansion of CAG repeats occurs in HD patients.

Purpose of the Study:

  • To investigate the concept of an intracellular pathogenic threshold for CAG repeat expansion in HD.
  • To determine the empirical range for this threshold using existing data.
  • To discuss methods for better determination of the cellular pathogenic threshold in manifest HD.

Main Methods:

  • Review and assessment of evidence from HD studies and related repeat expansion diseases.
  • Mathematical modeling of CAG repeat expansion dynamics.
  • Analysis of age-dependent and tissue-specific expansion patterns.

Main Results:

  • A two-step mechanism involving inherited CAG length and an intracellular pathogenic threshold is proposed.
  • Mathematical modeling suggests a threshold around 115 CAG repeats.
  • Empirical evidence places the intracellular pathogenic threshold between 60-100 CAG repeats, likely higher.

Conclusions:

  • The intracellular pathogenic threshold is critical for understanding HD pathogenesis.
  • Determining this threshold is key for developing targeted HD therapies.
  • Further research is needed to precisely define the cellular pathogenic threshold in manifest HD.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.9K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
146
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.2K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
548